Human Fibroblasts with Mutations in COL5A1 and COL3A1 Genes Do Not Organize Collagens and Fibronectin in the Extracellular Matrix, Down-regulate α2β1 Integrin, and Recruit αvβ3 Instead of α5β1 Integrin*
Human Fibroblasts with Mutations in COL5A1 and COL3A1 Genes Do Not Organize Collagens and Fibronectin in the Extracellular Matrix, Down-regulate α2β1 Integrin, and Recruit αvβ3 Instead of α5β1 Integrin*
复制标题
DOI:
10.1074/jbc.m312609200
复制
发表时间:
2004-04
影响因子:
4.8
通讯作者:
N. Zoppi;R. Gardella;A. De Paepe;S. Barlati;M. Colombi
中科院分区:
文献类型:
--
作者:
N. Zoppi;R. Gardella;A. De Paepe;S. Barlati;M. Colombi
Dermal fibroblasts derived from types I and IV Ehlers-Danlos syndrome (EDS) patients, carrying mutations in COL5A1 and COL3A1 genes, respectively, synthesize aberrant types V and III collagen (COLL) and show defective organization of these proteins into the extracellular matrix (ECM) and high reduction of their functional receptor, the α2β1 integrin, compared with control fibroblasts. EDS cells also show reduced levels of fibronectin (FN) in the culture medium and lack an FN fibrillar network. Finally, EDS cells prevalently organize αvβ3 integrin instead of α5β1 integrin. The αvβ3 integrin, distributed on the whole EDS cell surface, shows FN binding and assembly properties when the cells are treated with purified FN. Treatment of EDS cells with purified COLLV or COLLIII, but not with FN, restores the control phenotype (COLL+, FN+, αvβ3–, α5β1+, α2β1+). Function-blocking antibodies to COLLV, COLLIII, or α2β1 integrin induce in control fibroblasts an EDS-like phenotype (COLL–, FN–, αvβ3+, α5β1–, α2β1–). These results show that in human fibroblasts α2β1 integrin organization and function are controlled by its ligand, and that the α2β1-COLL interaction, in turn, regulates FN integrin receptor recruitment: high α2β1 integrin levels induce α5β1 integrin organization, while low α2β1 integrin levels lead to αvβ3 integrin organization.